Democrats have accused Robert Kennedy Jr. of making claims without scientific research to back them and say his claims are ...

Morning. Today, we discuss how Duchenne patients and their families are responding to the shelving of Sarepta Therapeutics’ ...

Experts on the panel shared many of the same views around SSRIs, arguing the risks of the drugs during pregnancy are greater ...

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...

A Food and Drug Administration panel discussing the use of antidepressants during pregnancy Monday largely amounted to ...

Obstetricians and psychiatrists are concerned about a recent FDA panel spreading misinformation about the potential harms of using SSRIs during pregnancy and postpartum.

Kennedy Jr.On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include ...

An FDA advisory panel concludes that the efficacy of brexpiprazole, when started concurrently with sertraline, has not been ...

NBC News medical contributor Dr. Natalie Azar reports on the FDA panel discussion of the use of antidepressants during ...

Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in ...

An FDA panel meeting featured a heated dialogue over whether fluoride supplements could pose health risks to children. Here's ...

Majority of FDA advisory panel members found risks outweigh benefits. July 14, 2010 — -- The blockbuster diabetes drug Avandia is likely to be sold in a strikingly different way, even if the ...